文献速递肾癌与肾肿瘤

临床T1a期肾细胞癌治疗中的性别差异

Gender Differences in the Clinical Management of clinical T1a Renal Cell Carcinoma.
PubMed 文献 · Urology · 2020-09-02

结果显示指南发布后RN总体减少(OR=0.44,P<.001),但女性在指南前后均更可能接受RN(OR=1.27和1.37,均P<.001),尽管女性病理升级和高分级比例更低。

要点

  • AUA指南发布后cT1a肾癌根治性肾切除总体减少。
  • 女性在指南前后均更可能接受根治性肾切除。
  • 女性病理升级和高分级风险低于男性。

核心结论

  • cT1a肾细胞癌治疗存在持续性别差异,女性接受根治性肾切除的 odds 更高,尽管其病理升级和高分级风险更低。

研究设计与样本

  • 采用多变量混合效应逻辑回归分析指南发布前(2004-2009)和发布后(2010-2013)与根治性肾切除相关的因素。

主要发现

  • 指南发布后根治性肾切除的总体似然比降低(OR=0.44,P<.001)。
  • 女性在指南发布前(OR=1.27,P<.001)和发布后(OR=1.37,P<.001)接受根治性肾切除的 odds 均高于男性。
  • 肿瘤大小>2 cm在指南前后均与根治性肾切除 odds 增加相关(OR=2.61,P<.001和OR=2.51,P<.001)。
  • 指南发布后,女性病理升级的 odds 显著更低(OR=0.75,P=.024),高分级病理的 odds 也更低(OR=0.71,P<.001)。

临床怎么用

  • 临床医生在为cT1a肾细胞癌患者制定手术方案时,应意识到女性患者接受根治性肾切除的 odds 更高,需结合指南推荐优先考虑保留肾单位手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate gender differences in the management of clinical T1a (cT1a) renal cell carcinoma (RCC) before and after release of the AUA guidelines for management in 2009, which prioritized nephron-sparing approaches. METHODS: Patients aged ≥66 years diagnosed with cT1a RCC from 2004 to 2013 in Surveillance, Epidemiology, and End Results-Medicare were analyzed. Multivariable mixed-effects logistic regression models were used to evaluate factors associated with radical nephrectomy (RN) for cT1a RCC before (2004 to 2009) and after (2010 to 2013) guidelines release. Predictors of pathologic T3 upstaging and high grade pathology in the postguidelines period were examined using multivariable logistic regression among patients who underwent RN or partial nephrectomy. RESULTS: Twelve thousand four hundred and two patients with cT1a RCC were identified, 42% of whom were women. Overall, the likelihood of RN decreased postguidelines (odds ratio [OR] = 0.44, P <.001), but women were at increased odds of undergoing RN both before and after guideline release (OR = 1.27, P <.001 and OR = 1.37, P <.001, respectively) upon multivariable mixed-effects logistic regression. Tumor size >2 cm was also associated with increased likelihood of RN before and after guidelines (OR = 2.61, P <.001 and OR = 2.51, P <.001, respectively). In the postguidelines period, women had significantly lower odds of pathologic upstaging (OR = 0.75, P = .024) and harboring high grade pathology (OR = 0.71, P <.001) compared to men. CONCLUSION: Gender differences persist in the management of cT1a RCC, with women having higher odds of undergoing RN, even after release of AUA guidelines and despite having lower odds of pathologic upstaging and high-grade disease.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Metcalf MR, Cheaib JG, Wainger J, et al. Gender Differences in the Clinical Management of clinical T1a Renal Cell Carcinoma. Urology. 2020. PMID: 32890618. doi:10.1016/j.urology.2020.08.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。